These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 8852532

  • 1. Citalopram in the treatment of early-onset panic disorder and school phobia.
    Lepola U, Leinonen E, Koponen H.
    Pharmacopsychiatry; 1996 Jan; 29(1):30-2. PubMed ID: 8852532
    [Abstract] [Full Text] [Related]

  • 2. [Citalopram in the treatment of panic disorders and school phobia in children and adolescents].
    Lepola U, Leinonen E, Koponen H.
    Duodecim; 1994 Jan; 110(1):60-2. PubMed ID: 7555751
    [No Abstract] [Full Text] [Related]

  • 3. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A.
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [Abstract] [Full Text] [Related]

  • 4. [Neurobiology and pharmacotherapy of social phobia].
    Aouizerate B, Martin-Guehl C, Tignol J.
    Encephale; 2004 Sep; 30(4):301-13. PubMed ID: 15538306
    [Abstract] [Full Text] [Related]

  • 5. Citalopram controls phobic symptoms in patients with panic disorder: randomized controlled trial.
    Leinonen E, Lepola U, Koponen H, Turtonen J, Wade A, Lehto H.
    J Psychiatry Neurosci; 2000 Jan; 25(1):24-32. PubMed ID: 10721681
    [Abstract] [Full Text] [Related]

  • 6. Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia.
    Bouwer C, Stein DJ.
    J Affect Disord; 1998 Apr; 49(1):79-82. PubMed ID: 9574863
    [Abstract] [Full Text] [Related]

  • 7. A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder.
    Dannon PN, Iancu I, Lowengrub K, Gonopolsky Y, Musin E, Grunhaus L, Kotler M.
    Clin Neuropharmacol; 2007 Apr; 30(6):326-34. PubMed ID: 18090457
    [Abstract] [Full Text] [Related]

  • 8. The effect of citalopram in panic disorder.
    Wade AG, Lepola U, Koponen HJ, Pedersen V, Pedersen T.
    Br J Psychiatry; 1997 Jun; 170():549-53. PubMed ID: 9330022
    [Abstract] [Full Text] [Related]

  • 9. Serotonin, panic disorder and agoraphobia: short-term and long-term efficacy of citalopram in panic disorders.
    Humble M, Wistedt B.
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 5():21-39. PubMed ID: 1431019
    [Abstract] [Full Text] [Related]

  • 10. Predictors of symptom resolution in panic disorder after one year of pharmacological treatment: a naturalistic study.
    Marchesi C, Cantoni A, Fontò S, Giannelli MR, Maggini C.
    Pharmacopsychiatry; 2006 Mar; 39(2):60-5. PubMed ID: 16555166
    [Abstract] [Full Text] [Related]

  • 11. Citalopram in social phobia.
    Kosieradzki PH.
    J Am Acad Child Adolesc Psychiatry; 2001 Oct; 40(10):1126-7. PubMed ID: 11589525
    [No Abstract] [Full Text] [Related]

  • 12. Patient-reported outcomes of quality of life, functioning, and depressive symptom severity in major depressive disorder comorbid with panic disorder before and after SSRI treatment in the star*d trial.
    IsHak WW, Mirocha J, Christensen S, Wu F, Kwock R, Behjat J, Pi S, Akopyan A, Peselow ED, Cohen RM, Elashoff D.
    Depress Anxiety; 2014 Aug; 31(8):707-16. PubMed ID: 23861180
    [Abstract] [Full Text] [Related]

  • 13. Serotonin in panic disorder and social phobia.
    Sheehan DV, Raj BA, Trehan RR, Knapp EL.
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():63-77. PubMed ID: 7911142
    [Abstract] [Full Text] [Related]

  • 14. What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
    Bandelow B, Baldwin DS, Dolberg OT, Andersen HF, Stein DJ.
    J Clin Psychiatry; 2006 Sep; 67(9):1428-34. PubMed ID: 17017830
    [Abstract] [Full Text] [Related]

  • 15. Panic disorder and social phobia: current treatments and new strategies.
    Davidson JR, Connor KM, Sutherland SM.
    Cleve Clin J Med; 1998 Sep; 65 Suppl 1():SI39-44; discussion SI45-7. PubMed ID: 12033205
    [Abstract] [Full Text] [Related]

  • 16. Reboxetine and citalopram in panic disorder: a single-blind, cross-over, flexible-dose pilot study.
    Seedat S, van Rheede van Oudtshoorn E, Muller JE, Mohr N, Stein DJ.
    Int Clin Psychopharmacol; 2003 Sep; 18(5):279-84. PubMed ID: 12920388
    [Abstract] [Full Text] [Related]

  • 17. Citalopram: new indication. No advantage.
    Prescrire Int; 1999 Feb; 8(39):18-9. PubMed ID: 10557570
    [Abstract] [Full Text] [Related]

  • 18. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.
    Stahl SM, Gergel I, Li D.
    J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946
    [Abstract] [Full Text] [Related]

  • 19. Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder.
    Shlik J, Aluoja A, Vasar V, Vasar E, Podar T, Bradwejn J.
    J Psychiatry Neurosci; 1997 Nov; 22(5):332-40. PubMed ID: 9401314
    [Abstract] [Full Text] [Related]

  • 20. Anxiety sensitivity and modulation of the serotonergic system in patients with PD.
    Romano P, van Beek N, Cucchi M, Biffi S, Perna G.
    J Anxiety Disord; 2004 Nov; 18(3):423-31. PubMed ID: 15125987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.